Investor Relations Alimera Sciences

Skip to main navigation. Diabetic Macular Edema DME. Retinal Vein Occlusion RVO. Age-Related Macular Degeneration AMD. Alimera Sciences primary focus is on ILUVIEN. Fluocinolone acetonide intravitreal implant 0.19 mg. ILUVIEN is an intravitreal implant of fluocinolone acetonide and is the first DME treatment to deliver 36 months of continuous, low-dose corticosteroid therapy with a single injection. Feb 28, 2018. Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results. 2018 A.

OVERVIEW

The web page investor.alimerasciences.com presently has a traffic classification of zero (the smaller the more users). We have analyzed eighteen pages inside the web page investor.alimerasciences.com and found seventy-two websites referring to investor.alimerasciences.com. I unearthed three mass communication sites acquired by investor.alimerasciences.com.
Pages Parsed
18
Links to this site
72
Social Links
3

INVESTOR.ALIMERASCIENCES.COM TRAFFIC

The web page investor.alimerasciences.com is seeing alternating quantities of traffic all through the year.
Traffic for investor.alimerasciences.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.alimerasciences.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.alimerasciences.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEBSITE

WHAT DOES INVESTOR.ALIMERASCIENCES.COM LOOK LIKE?

Desktop Screenshot of investor.alimerasciences.com Mobile Screenshot of investor.alimerasciences.com Tablet Screenshot of investor.alimerasciences.com

INVESTOR.ALIMERASCIENCES.COM SERVER

I found that the main root page on investor.alimerasciences.com took two hundred and eight milliseconds to download. I could not discover a SSL certificate, so therefore our parsers consider this site not secure.
Load time
0.208 sec
SSL
NOT SECURE
IP
199.239.183.19

BROWSER IMAGE

SERVER SOFTWARE AND ENCODING

We diagnosed that investor.alimerasciences.com is weilding the nginx os.

HTML TITLE

Investor Relations Alimera Sciences

DESCRIPTION

Skip to main navigation. Diabetic Macular Edema DME. Retinal Vein Occlusion RVO. Age-Related Macular Degeneration AMD. Alimera Sciences primary focus is on ILUVIEN. Fluocinolone acetonide intravitreal implant 0.19 mg. ILUVIEN is an intravitreal implant of fluocinolone acetonide and is the first DME treatment to deliver 36 months of continuous, low-dose corticosteroid therapy with a single injection. Feb 28, 2018. Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results. 2018 A.

PARSED CONTENT

The web page had the following in the homepage, "Alimera Sciences primary focus is on ILUVIEN." I viewed that the web site stated " Fluocinolone acetonide intravitreal implant 0." They also said " ILUVIEN is an intravitreal implant of fluocinolone acetonide and is the first DME treatment to deliver 36 months of continuous, low-dose corticosteroid therapy with a single injection. Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results."

ANALYZE SUBSEQUENT WEB PAGES

Alkermes PLC Investor Relations Corporate Overview

Q2 2015 Alkermes plc Earnings Conference Call. Alkermes plc Reports Second Quarter 2015 Financial Results. Alkermes to Host Conference Call to Discuss Second Quarter 2015 Financial Results. Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting.

Investors ALLETE, Inc.

ALLETE common stock trades on the New York Stock Exchange under the ticker symbol ALE, and has paid consecutive dividends since 1950. The company has been headquartered in Duluth, Minnesota since 1906. ALLETE Clean Energy to Build Montana Wind Energy Facility to Supply Electricity to NorthWestern Energy under Power Sale Agreement. ALLETE Clean Energy to Sell Phase II of Thunder Spirit Wind Farm to Montana-Dakota Utilities.

Allscripts - Investor Relations

Click here to add this event to your calendar. Q2 2015 Allscripts Healthcare Solutions, Inc.

ALTERA - Investor Relations - Investor Relations

Looking for a specific product? New to programmable devices? New to FPGAs Resource Center. By Ron Wilson, Editor-in-Chief.

Altria - Investors - At-A-Glance

Electronic Delivery of Annual Proxy Materials. 2015 Annual Meeting of Shareholders. Dividends are declared and approved only at the discretion of the Board of Directors.